Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)

DEVICE2 trials

Sponsors

Stimvia s.r.o.

Conditions

Essential TremorParkinson DiseaseParkinson's Disease

Unknown Phase

Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

CompletedNCT06036368

Stimvia s.r.o.Essential Tremor, Parkinson's Disease

Start: 2023-09-15End: 2024-06-30Updated: 2024-08-21

24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

RecruitingNCT06570421

Stimvia s.r.o.Essential Tremor, Parkinson Disease

Start: 2024-07-19End: 2026-12-31Target: 20Updated: 2024-08-26